Angiopoietin-1 enhances neutrophil chemotaxis in vitro and migration in vivo through interaction with CD18 and release of CCL4 by Burnett, A et al.
1Scientific RepoRts | 7: 2332  | DOI:10.1038/s41598-017-02216-y
www.nature.com/scientificreports
Angiopoietin-1 enhances 
neutrophil chemotaxis in vitro 
and migration in vivo through 
interaction with CD18 and release 
of CCL4
Amanda Burnett1, Ingrid Gomez1, David Davila De Leon2,3, Mark Ariaans1, Pavlos Progias4, 
Richard A. Kammerer5, Guillermo Velasco2,3, Marie Marron1, Paul Hellewell  6 & Victoria 
Ridger  1
Angiopoietins are a family of growth factors that are ligands for the tyrosine kinase receptor, Tie2. 
Angiopoietin 1 (Ang-1) is agonistic for Tie2, plays a key role in blood vessel maturation and stability 
and has been shown to possess anti-inflammatory properties. However, Tie2 expression has been 
demonstrated on human neutrophils and the observation that neutrophils migrate in response to 
Ang-1 in vitro has confounded research into its exact role in inflammation as well as its potential use 
as a therapeutic agent. We used a mouse model of peritoneal neutrophilic inflammation to determine 
if Ang-1 could stimulate neutrophil migration in vivo. Tie2 expression was demonstrated on mouse 
neutrophils. In addition, recombinant human Ang-1 induced significant chemotaxis of isolated mouse 
neutrophils in a Tie2- and CD18-dependent manner. Subsequently, co-immunoprecipitation of Ang-1 
and CD18 demonstrated their interaction. Intraperitoneal injection of an engineered angiopoietin-1, 
MAT.Ang-1, induced significant neutrophil migration into the peritoneum and a significant increase 
in the levels of CCL4 in peritoneal lavage fluid. Depletion of resident peritoneal macrophages prior to, 
or concomitant injections of an anti-CCL4 antibody with MAT.Ang-1 resulted in a significant reduction 
in neutrophil recruitment. These data indicate a pro-inflammatory role for Ang-1 with respect to 
neutrophil recruitment.
The inflammatory process is of great importance in host defence but is also a major contributor to numerous 
disease processes1. During an inflammatory response, neutrophils act as first-responders and are recruited to the 
injury site. This recruitment is orchestrated by the expression of adhesion molecules on the surface of both the 
neutrophil and the endothelial cells in addition to the release of chemotactic cytokines that guide the neutrophils 
to the site of injury2.
The angiopoietin family of growth factors are best known for their role in angiogenesis and vascular home-
ostasis. However, they have also been shown to have effects beyond these conventional roles, specifically in the 
regulation of vascular inflammation. Ang-1 is a 70 kDa glycoprotein3 produced by pericytes3, 4. It acts as an ago-
nistic ligand for Tie2 and both are essential for normal vessel development, demonstrating a lethal phenotype in 
mouse knockout studies4–6. Evidence implies that Ang-1 produces a constant basal signal7, which maintains the 
integrity and stability of the endothelium in mature vessels. In addition to this, a number of studies have reported 
that Ang-1 can inhibit vessel leakage induced by inflammatory agents such as VEGF and mustard oil8, 9. Kim et al. 
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demonstrated that Ang-1 also inhibits VEGF-induced expression of endothelial cell adhesion molecules ICAM-1, 
VCAM-1 and E-selectin10, which are involved in recruiting leukocytes in inflammatory responses.
As well as its role as a mediator of vascular integrity, a potential alternative role of the angiopoietin/Tie2 sys-
tem in inflammation has been implicated; expression of Tie2 has been demonstrated on inflammatory cells such 
as neutrophils11, 12, monocytes13, 14 and eosinophils15. Moreover there have been several studies revealing that 
the angiopoietins are able to directly activate neutrophils as well as endothelial cells11, 12, 16. Sturn et al.12 demon-
strated Tie2-dependent migration of human neutrophils in response to Ang-1 in vitro12. Additionally, Lemieux 
et al. (2005) observed that Ang-1 can cause P-selectin translocation to the surface of, and neutrophil adhesion 
to, endothelial cells through phosphorylation of the Tie2 receptor11. However, there is currently no evidence that 
angiopoietins can act as pro-inflammatory chemoattractants in vivo.
Although Ang-1 has been heralded as a potential novel compound for treatment of inflammatory diseases17, 18, 
studies demonstrating the expression of Tie2 on neutrophils and their responsiveness to angiopoietins have high-
lighted the need for further investigation. We have used a mouse model in order to investigate whether exogenous 
Ang-1 induces neutrophilic inflammation in vivo. We demonstrate that mouse neutrophils express Tie2 and 
migrate towards recombinant human Ang-1 in vitro in a Tie2 and CD18-dependent manner. In addition, the 
stable MAT.Ang-1 induces neutrophil migration and cytokine release in vivo. These novel data demonstrate that 
Ang-1 can act in a pro-inflammatory manner, not only in vitro, but also in vivo.
Results
Mouse neutrophils express Tie2. We first determined whether mouse neutrophils express Tie2. Flow 
cytometry analysis, using Ly6G positivity to gate on the neutrophil population in lysed mouse whole blood, 
demonstrated expression of Tie2 on mouse neutrophils (Fig. 1A and B); as previously shown, Tie2 expression was 
also found on monocytes as previously described19 but we were unable to detect its expression on lymphocytes 
(Data not shown). Permeabilising the cells resulted in an increase in detectable levels of Tie2 (Fig. 1B) suggesting 
an intracellular source as well as surface expression. The level of Tie2 expression on mouse neutrophils was insuf-
ficient for direct detection by immunoblotting. Therefore, immunoprecipitation was used to concentrate the Tie2 
protein. Subsequent immunoblot analysis demonstrated that mouse neutrophils express Tie2 protein (Fig. 1C).
Ang-1 induces neutrophil chemotaxis in vitro. Having established that mouse neutrophils express Tie2, 
we then investigated whether Ang-1 could act as a chemoattractant. We found that Ang-1 significantly (P < 0.01) 
increased mouse neutrophil migration compared to buffer control, in a concentration dependent manner, with 
a maximal effect observed at 0.7 µg/ml (Fig. 2A). This was similar to the response seen with Ang-2. Increasing 
the concentration of Ang-1 resulted in a reduction in chemotaxis. Mouse KC (keratinocyte chemoattractant; 
10−6 M) was used as a positive control. To determine the role of Tie2 in this response, mouse neutrophils were 
treated with purified monoclonal rat anti-mouse Tie2 antibody. This resulted in a significant decrease (P < 0.01) 
in neutrophil migration to Ang-1 but not KC (Fig. 2B). However, the response to Ang-1 was only partially atten-
uated. To further elucidate the mechanism by which Ang-1 induced mouse neutrophil chemotaxis, we investi-
gated the role of the adhesion molecule CD18 (β2 integrin) as its role in neutrophil adhesion and migration is 
well-established20–22. Incubation of mouse neutrophils with anti-mouse CD18 (GAME-46 7.5 μg/106 cells) signif-
icantly reduced (P < 0.001) migration to both Ang-1 and the positive control KC compared to the isotype control 
(Fig. 2C). Chemoattractants can increase the expression of surface adhesion molecules such as CD1823. In order 
to determine whether Ang-1 acts via increasing surface expression of Tie2 or CD18, neutrophils were incubated 
with increasing concentrations of Ang-1 and expression determined by flow cytometry. It was found that after 
3 h (same exposure as chemotaxis assays) Ang-1 did not induce a significant change in surface CD18 or Tie2 
Figure 1. Tie2 expression on mouse peripheral blood neutrophils. (A) Ly6G positivity was used to gate on 
neutrophils using forward and side scatter and Tie2 expression demonstrated as a log shift in fluorescence (FL-
2) compared to isotype control. (B) For quantification of expression in unpermeabilised and permeabilised 
neutrophils, the mean fluorescence intensity (MFI) was determined. Results are presented as mean ± SEM 
(n = 3) and analysed for statistical significance using two-way ANOVA followed by Bonferroni’s post test for 
multiple comparisons. (C) Immunoprecipitation with anti-human Tie2 antibody resolved by SDS-PAGE- and 
probed with anti-mouse Tie2 antibody. Tie2 protein is detected at approximately 140 kDa. Lane 1: HUVEC 
lysate (positive control); lane 2: Mouse neutrophil immunoprecipitate.
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expression (Supplementary Fig. 1). In conclusion, Ang-1 induces neutrophil chemotaxis in a partially Tie2 and 
CD18 dependent manner that does not involve significant enhancement of surface molecule expression.
Ang-1 binds to CD18 on neutrophils. Angiopoietins have previously been shown to directly interact 
with integrins24, 25. Therefore, to investigate the mechanism by which Ang-1 could induce chemotaxis in a CD18 
dependent manner, we carried out co-immunoprecipitation experiments to determine if Ang-1 was able to 
directly bind to CD18 on the surface of neutrophils. We found a detectable band of the appropriate size after pull 
down with anti-CD18 coated beads (Fig. 2D). However, this was at very low levels and required cross-linking in 
order for the band to be detected (Supplementary Fig. S2). These data suggest that Ang-1 is indeed able to bind 
directly to surface CD18, although at very low levels or weakly.
Neutrophils migrate in response to MAT.Ang-1 in vivo. MAT.Ang-1 was used in these experiments 
as it is more stable in vivo than recombinant Ang-126, which has been shown to be degraded in vivo after 1–2 h. 
Intraperitoneal injection of MAT.Ang-1 (33 µg/mouse, a dose previously used in mice27) induced significant 
(P < 0.001) accumulation of neutrophils in the peritoneal cavity compared to saline controls after 4 h (Fig. 3A). 
Cytospins produced from the peritoneal lavage fluid of mice injected with saline at 4 h contained few neutrophils 
in contrast to cytospins from mice injected with MAT.Ang-1 (Fig. 3B). In addition injection of irrelevant human 
protein (human serum albumin, 33 µg/mouse) did not induce neutrophil migration over 4 h (mean ± SEM = 0.0
33 ± 0.02 × 106 neutrophils/ml, n = 4).
From the above experiments we could not determine whether MAT.Ang-1 was acting directly on neutrophils 
as a chemoattractant, as found in the in vitro experiments, or whether there were indirect effects, for example 
via inducing release of inflammatory mediators from resident peritoneal macrophages. Therefore, macrophages 
were depleted from the peritoneal cavity through administration of liposome-encapsulated clodronate28 result-
ing in an 85% reduction in the number of macrophage/monocytes measured by peritoneal lavage (Fig. 4A and 
Supplementary Fig. S3). This effect was specific to tissue macrophages and no effect on circulating leukocyte levels 
was observed (Supplementary Fig. S3). Macrophage depletion by injection of clodronate liposomes 48 h prior to 
the administration of MAT.Ang-1 significantly (P < 0.05) reduced neutrophil migration compared to that meas-
ured in mice injected with control liposomes, although only a partial reduction was observed (Fig. 4B).
Figure 2. Chemotactic response of mouse neutrophils to rhAng-1 (A) and rhAng-2 (B). Dose-response effects 
of rhAng-1 and rhAng-2 on isolated mouse peripheral blood neutrophil chemotaxis. KC (10−7 M) was used as a 
positive control. Results presented as mean ± SEM (n = 4) and analysed for statistical significance using ANOVA 
followed by Dunnett’s comparing all to buffer control. *P < 0.05 **P < 0.01 ***P < 0.001. The effect of isotype 
control (rat IgG1), anti-Tie2 (12 µg/ml; 6 µg/10−6 cells) (C) or anti-CD18 (GAME-46) (D) (15 µg/ml; 7.5 µg/10−6 
cells) on chemotaxis induced by KC (10−7 M) or rhAng-1 (0.7 µg/ml). Results presented as mean ± SEM (n = 3–4) 
and analysed for statistical significance using two-way ANOVA followed by Bonferroni’s test for multiple 
comparisons. *P < 0.05 **P < 0.01 ***P < 0.001 compared to isotype control. (E) Neutrophils were treated with 
rhAng-1 (0.7 µg/106 neutrophils) or PBS and subjected to extracellular crosslinking. Protein levels of Ang-1 co-
immunoprecipitated with CD18 were detected by immunoblotting and quantified using densitometry. Results are 
expressed as mean ± SEM, n = 3 and analysed for statistical significance using a paired t-test.
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Role of CCL4 (MIP-1β) in MAT.Ang-1-induced neutrophil migration. Investigation into inflam-
matory mediators present in the lavage fluid collected 4 h after i.p. injection of MAT.Ang-1 compared to 
saline showed a significant (P < 0.05) increase in the level of macrophage inflammatory protein-1β (MIP-1β) 
known as CCL4 (Fig. 4C). There were no significant differences between the levels of monocyte chemotactic 
protein-1 (MCP-1), known as CCL2, between saline and MAT.Ang-1 treated mice (PBS: 30.9 ± 0.9; MAT.Ang-1: 
33.2 ± 3.5 pg/ml). Levels of granulocyte macrophage colony-stimulating factor (GM-CSF), interleukin-4 (IL-4), 
interleukin-13 (IL-13), interleukin-17A (IL-17A), keratinocyte chemoattractant (KC), macrophage inflammatory 
protein-1α (MIP-1 α) or tissue necrosis factorα (TNFα) were below the detection limit for both saline and MAT.
Ang-1 injected mice. To determine whether CCL4 release played a role in the neutrophil migration observed after 
i.p. injection of MAT.Ang-1, a combined injection of MAT.Ang-1 and anti-mouse CCL4 (MAB451) or rat IgG2a 
isotype control (both given at 50 µg/ml) was administered and peritoneal lavage performed 4 h later. Anti-mouse 
CCL4 caused a partial, but significant (P < 0.05) attenuation of neutrophil migration into the peritoneal cavity 
compared to isotype control (Fig. 4D). Therefore MAT.Ang-1 induces local release of CCL4 leading to recruit-
ment of neutrophils. In order to determine whether the source of CCL4 was the resident macrophages, CCL4 
secretion from isolated peritoneal macrophages was assessed. However, there was no measurable release of CCL4 
from peritoneal macrophages after 4 h stimulation with rhAng-1, suggesting that in this in vitro model, Ang-1 
does not induce CCL4 release from peritoneal macrophages.
Discussion
In this study we have investigated whether Ang-1 can modulate recruitment of neutrophils in vivo. In order to 
attribute any findings to binding of Ang-1 to Tie2, we have shown expression of Tie2 on mouse neutrophils using 
immunoprecipitation and flow cytometry although, as with human neutrophils, expression of the receptor was 
at a very low level11, 12. These results add to those of Lemieux et al. (2005) who demonstrated Tie2 phosphoryla-
tion in human neutrophils by immunoblotting using whole cell lysate with an anti-phospho-specific Tie2 IgG11. 
Interestingly, permeabilisation of neutrophils showed increased Tie2 expression indicating neutrophils have an 
intracellular store of the receptor, possibly due to receptor internalisation as shown by Bogdanovic et al. for 
endothelial cells29.
Tie2 has been shown to be expressed in hematopoietic stem cells30. This implies that Tie2 expression is sus-
tained through hematopoietic progenitor cell development into mature neutrophils, which again raises the ques-
tion of the role of the Tie2/angiopoietin system in the inflammatory response. One possible role is in neutrophil 
recruitment; Ang-1 has been shown in vitro to be chemoattractant for human neutrophils12, 16 and andenoviral 
administration of Ang-1 has been shown to increase neutrophil infiltration in a model of folic acid induced 
nephrotoxicity in mice31. However, another study by Hegeman et al. demonstrated rhAng-1 reduced the number 
of neutrophils present in bronchoalveolar lavage fluid in a mouse model of ventilator-induced lung injury32. 
Here we demonstrate for the first time that mouse neutrophils migrate towards Ang-1 both in vitro and in vivo. 
Consistent with other chemoattractants, the migratory response of mouse neutrophils Ang-1 produced a bell 
shaped curve33, 34 with higher concentrations resulting in a reduced migratory response. Our flow cytometry data 
suggests that this is not a result of a significant reduction in surface expression of either Tie2 or CD18, unlike that 
described for CXCR1/2 in response to CXCL835.
Tie2 expression on mouse neutrophils is very low and angiopoietins have been shown to bind not only to Tie2 
but also to integrins24, 36, 37; therefore it was important to show that the chemotaxis observed in mouse neutro-
phils was specifically mediated via the Tie2 receptor. Treatment of neutrophils with anti-mouse Tie2 antibody 
significantly reduced Ang-1-induced neutrophil migration. This reduction was specific to chemotaxis induced by 
rhAng-1 as the response to KC was unaffected, indicating that the mouse neutrophil Tie2 receptor is not involved 
in the latter response. However, Tie2 inhibition only partially attenuated the chemotactic response to Ang-1 sug-
gesting other mechanisms may also play a role in Ang-1-induced mouse neutrophil migration.
Figure 3. Neutrophil migration in response to MAT.Ang-1 in vivo. MAT.Ang-1 (33 µg/mouse) or saline control 
were injected i.p. into C57/Bl6 mice. After 0–4 h peritoneal lavage was performed and the total neutrophil count 
was calculated using total leukocyte and differential counts. (A) Results are presented as mean ± SEM (n = 3–5 
mice) and analysed for statistical significance using two-way ANOVA followed by Bonferroni’s test for multiple 
comparisons. ***P < 0.001. (B) Cytospins were performed using lavage samples taken at 4 h. Hema Gurr® was 
used to stain and images were taken at ×200 magnification. Scale bar = 50 µm.
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CD18 (β2-integrin) is known to be involved in migration of neutrophils induced by multiple chemoattract-
ants21, 38. In addition to the role of Tie2, inhibiting CD18 using a blocking antibody caused migration to be signif-
icantly attenuated. This was not due to Ang-1 inducing changes in the surface expression of CD18 on the surface 
of neutrophils. This is in agreement with published data from Sturn et al.12 where no significant changes could be 
detected in L-selectin and CD11b expression using flow cytometry after incubation with angiopoietins12. As men-
tioned above, the angiopoietins are able to interact with integrins directly and we found that this was indeed the 
case on neutrophils. It is likely that direct interaction of Ang-1 with CD18 plays a role in the migratory response 
observed but the exact mechanism for this remains to be elucidated. One possibility is that this interaction leads 
to CD18-mediated signalling that could impact on multiple responses in the neutrophil39, 40. Interestingly, the 
Tie2 receptor has also been shown to interact directly with integrins36 and it is possible that clustering of Tie2 with 
integrins occurs on the cell surface.
Intraperitoneal injection of MAT.Ang-1, at a dose previously shown to reverse LPS-induced inflammation27, 
induced migration of neutrophils into the peritoneal cavity of C57/Bl6 mice. This is the first time Ang-1 has been 
shown to elicit such pro-inflammatory responses in vivo. Depletion of peritoneal macrophages resulted in a par-
tial inhibition of this migration suggesting that MAT.Ang-1 mediates at least some of its effects via stimulation 
of macrophages. The residual neutrophil migration may have been due to MAT.Ang-1 acting directly on neutro-
phils, as seen with rhAng-1 in vitro. However, as the depletion of macrophages was only approximately 85% it 
may also be possible that the residual neutrophil migration may have been as a result of MAT.Ang-1 acting upon 
the remaining 15% of resident cells.
Cytometric bead array analysis of levels of a number of cytokines within the lavage fluid collected 4 hours after 
injection of MAT.Ang-1 revealed that only levels of CCL4 were significantly higher in the lavage fluid of MAT.
Ang-1 injected mice compared to those injected with saline. In vitro stimulation of peritoneal macrophages with 
Ang-1 did not result in a detectable release of CCL4 after 4 hours. Interestingly, Ang-1 has been shown to induce 
CCL4 expression in neutrophils in vitro, but release was found to be delayed, with significantly raised levels 
of CCL4 only detected after 24 h41. However, this may be altered in vivo. Blocking CCL4 significantly reduced 
the amount of neutrophil migration into the peritoneum but the source of CCL4 release remains unknown. 
However, as with macrophage depletion, there was still some residual neutrophil migration and levels did not 
return to those observed with saline. This may be due to incomplete inhibition by the antibody, but is more likely 
an indication that other mechanisms are involved in the response, such as an increase in neutrophil viability as 
demonstrated by Dumas et al.42. As both depletion of macrophages and blocking the actions of CCL4 did not 
completely inhibit neutrophil migration, it is possible that MAT.Ang-1 may act via a direct chemotactic action on 
neutrophils as seen in the in vitro chemotaxis experiments. These data suggest a pro-inflammatory role for Ang-1 
with respect to neutrophil migration, which appears contrary to many published studies where administration of 
Ang-1 in vivo attenuates inflammation and acts as a protective mediator8, 9, 43. However, this may be due to differ-
ences in exogenous Ang-1 compared to endogenous responses; we were unable to detect any Ang-1 in the lavage 
fluid from thioglycollate induced peritonitis suggesting that Ang-1 does not play a role in neutrophil recruitment 
in this model of neutrophilic inflammation.
In conclusion, this study demonstrates that Ang-1 has a role as a pro-inflammatory mediator, inducing mouse 
neutrophil migration both in vitro and in vivo. In vitro, this response was dependent on Tie2 and CD18 but was 
not due to an alteration in surface receptor expression. Furthermore, our in vivo data demonstrates a role for 
Ang-1 in neutrophil trafficking, potentially through a direct effect on neutrophils, but also through macrophage 
Figure 4. MAT.Ang-1 induced neutrophil migration after depletion of peritoneal macrophages. (A) C57/
Bl6 mice were administered with 250 µl control or clodronate liposomes i.p. After 48 h, peritoneal lavage was 
performed and the total monocyte/macrophage count was calculated using total and differential cell counts. 
(B) Liposomes were administered as above 48 h prior to injection of MAT.Ang-1 (33 µg/mouse i.p.). After 4 h, 
peritoneal lavage was performed and the total neutrophil count was calculated using total and differential cell 
counts. (C) CCL4 levels in peritoneal lavage fluid were measured by cytometric bead array 4 h after MAT.Ang-1 
administration (D) Rat anti-mouse CCL4 (MAB451) or rat IgG2a (both 50 µg/ml) were administered together 
with MAT.Ang-1 and neutrophil levels in lavage fluid measured after 4 h. Results are expressed as mean ± SEM 
(n = 3–5 mice). Statistical significance was analysed using an unpaired t-test. *P < 0.05, **P < 0.01, 
***P < 0.001.
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activation and release of CCL4. This raises the issue of the true role of the angiopoietins in the inflammatory 
process.
Materials and Methods
Animals. Male C57BL/6 (Harlan, Oxford, UK) mice were used. All procedures were approved by the 
University of Sheffield ethics committee and performed in accordance with the UK Home Office Animals 
(Scientific Procedures) Act 1986. All cardiac punctures were performed under sodium pentobarbital anesthesia, 
and all efforts were made to minimize suffering.
Mouse and human peripheral blood neutrophil isolation. Mouse peripheral blood neutrophils were 
isolated using a modified version of the negative immunomagnetic separation technique described by Cotter et 
al.44. Peripheral blood was incubated with the following monoclonal antibodies: anti-mouse CD2 (1.5 µg/106 lym-
phocytes), anti-mouse CD5 (2 µg/106 lymphocytes), anti-mouse CD45R (10 µg/106 lymphocytes) (all from Becton 
Dickinson, Oxford, UK), anti-mouse F4/80 (4 µg/106 monocytes) and anti-mouse CD115 (15 µg/106 monocytes) 
(both from AbD Serotec, Oxford, UK). Cells were then incubated with goat anti-rat IgG MicroBeads (20 µl/107 
cells, Miltenyi Biotec Ltd, Bisley, UK) at 4 °C for 15 min before neutrophils were negatively selected using a mag-
netic column. Differential counts showed that the neutrophil purity was between 90–98%.
For human studies, all experiments were approved by University of Sheffield Research Ethics Committee (ref-
erence SMBRER310) and were performed in accordance with the relevant guidelines and regulations. All subjects 
gave informed consent. Human peripheral blood neutrophils were isolated using density gradient separation as 
previously described45.
Mouse peritoneal macrophage isolation. Peritoneal lavage was performed on C57/Bl6 mice and resi-
dent macrophages isolated as previously described46. CCL4 release was measured after 4 h incubation with recom-
binant human (rhAng-1, 33 µg/ml; R&D systems, Abingdon, UK) or PBS using a commercial ELISA kit for mouse 
CCL4 (R&D systems, Abingdon, UK).
Human umbilical vein cell isolation and culture. Human umbilical vein cells were isolated and cultured 
as previously described47.
Flow cytometry. Blood was taken from C57/Bl6 mice by cardiac puncture. Red blood cells were lysed using 
erythrolyse (AbD Serotec, Oxford, UK). The cells were fixed using a kit from Ebiosciences (Hatfield, UK) which 
has paraformaldehyde based fixation buffer. In addition, samples were permeabilised using buffer containing 
0.1% saponin. After treatment, the cells were stained with PE conjugated monoclonal rat anti-mouse Tie2 (clone 
TEK4, Biolegend, San Diego, CA) or rat IgG1ĸ isotype control. After washing, the samples were analysed using 
a FACScan flow cytometer (Becton Dickinson, Oxford, UK) and CellQuest Pro software (Becton Dickinson, 
Oxford, UK). In order to analyse neutrophil specific expression of Tie2, the cells were stained with Ly6G (1A8 - 
Becton Dickinson, Oxford, UK) allowing the Ly6G+ve cells (neutrophils) to be identified.
Surface expression of Tie2 and CD18 after 3 h incubation with increasing concentrations of rhAng-1 was 
measured by flow cytometry in a similar manner to that described by Sturn et al.12 using PE- and FITC-conjugated 
antibodies against mouse Tie2 or CD18 respectively (Biolegend, San Diego, CA and Becton Dickinson, Oxford, 
UK respectively).
Immunoprecipitation and immunoblot analysis. Isolated neutrophils were washed twice with PBS. 
Cells were lysed (lysis buffer: 50 mM Tris pH 7.5, 50 mM NaCl, 1 mM NaF, 1 mM EGTA, 20% (v/v) Triton-X-100, 
protease inhibitor), vortexed and centrifuged at 12,000 g for 10 min at 4 °C. Protein content of the lysates was 
measured and equal amounts of protein used in the immunoprecipitation. Protein-G sepharose beads were 
washed with lysis buffer and 1–2 µg of monoclonal mouse anti-human Tie2 antibody (clone 33; Becton Dickinson 
Bioscience, Oxford, UK) was added to the beads. Cell lysate was incubated at 4 °C overnight with the antibody 
treated beads. The beads were pelleted, treated with 10 µl of sample buffer, boiled for 5 min at 95 °C and then 
resolved by SDS-PAGE. To run the samples, a Nupage™ 4–12% Bis Tris gel 1.0mm x10 well (Sigma-Aldrich, 
Poole, UK) was used. The membrane was blocked for 1 h using milk powder 5% (w/v) in PBS containing 0.1% 
(v/v) Tween. The primary antibody (polyclonal rabbit anti-mouse Tie2 antibody; Santa Cruz, Heidelberg, 
Germany) was added and the membrane was left shaking at 4 °C overnight. Any unbound antibody was removed 
by washing in PBS containing 0.1% (v/v) Tween three times for 15 min. A horseradish peroxidise (HRP) conju-
gated secondary antibody was added in PBS containing 0.1% (v/v) Tween for 1 h. The membrane was washed 
a further three times with PBS containing 0.1% (v/v) Tween. A Supersignal West Dura Extended Duration 
Substrate (ThermoFisher Scientific, Paisley, UK) was used to provide chemiluminescence for analysis. The blot 
was analysed on Chemi genius2 Bio Imaging System (Syngene, Cambridge, UK).
To investigate the interaction of Ang-1 and CD18, co-immunoprecipitation was performed as previously 
described48 with minimal modifications. Isolated human neutrophils were treated with rhAng-1 (0.7 µg/106 neu-
trophils) or PBS and the cross linker DTSSP following manufacturer’s instructions (ThermoFisher Scientific, 
Paisley, UK). Cells were then lysed (40 mM Hepes, 120 mM NaCl, 1 mM EDTA, 10 mM sodium pyrophosphate, 
10 mM sodium glycerophosphate, 50 mM sodium fluoride, 0.5 mM sodium orthovanadate, 0.3% CHAPS, 1 mM 
benzamidine and 0.1 mM PMSF) and the lysates (1–4 mg) precleared by incubating with 5–20 μl of protein G–
Sepharose (GE Healthcare Life Sciences, Little Chalfont, UK) conjugated to pre-immune IgG. The lysate extracts 
and only lysis buffer (negative control) were then incubated with 5–20 μl of protein G–Sepharose covalently con-
jugated to 5–20 μg of the anti-CD18 IgG (AbD Serotec, Oxford, UK). Immunoprecipitations were carried out 
overnight at 4 °C on a rotatory wheel. The immunoprecipitates were washed 4 times with lysis buffer, followed 
by 2 washes with kinase buffer (25 mM Hepes and 50 mM KCl) and resuspended in 30 μl of sample buffer (not 
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containing 2-mercaptoethanol) and filtered through a 0.22-μm Spin-X filter (Sigma-Aldrich, Poole, UK), fol-
lowed by addition of 2-mercaptoethanol (1% vol/vol). Samples were subjected to electrophoresis and immunoblot 
analysis with anti-CD18 and anti-angiopoietin-1 antibodies (R&D Systems, Abingdon, UK).
Neutrophil chemotaxis assay. Migration of mouse neutrophils in response to rhAng-1 (R & D Systems, 
Abingdon, UK) was performed using a 96-well chemotaxis chamber, which contained a polycarbonate membrane 
filter with 5 μm pores (NeuroProbe, Gaithersburg, MD) as previously described45, 49. A range of concentrations of 
recombinant human Ang-1 (rhAng-1) diluted in RPMI was placed in the bottom well. The mouse chemoattractant 
KC (10−7 M, Peprotech, London, UK) was used as a positive control. Mouse neutrophils were then added to the 
upper filter membranes and chemotaxis measured after a 3 h incubation period. The chemotaxis assay was repeated 
in the presence of saturating concentrations of the monoclonal antibodies anti-Tie2 (12 µg/ml; 6 μg/106 cells; clone 
TEK4, Biolegend, San Diego, CA,) and anti-CD18 (15 µg/ml; 7.5 μg/106 cells; clone GAME-46, BD Biosciences, 
Oxford, UK). Isotype controls for each of the antibodies were used at the same concentration. All antibodies were 
added to the neutrophil suspension dispersed onto the upper filter membrane at the start of the experiment.
MAT.Ang-1 or thioglycollate induced peritonitis. MAT.Ang-1 was produced as previously described27, 50  
by substituting the N-terminal with the short coiled-coil domain of chicken matrilin 1 (MAT) fused to the 
fibrinogen-like domain of native human Ang-1 imparting greater solubility (>95% vs. 60 to 70%) than native 
Ang-126, 50. To ensure there was no endotoxin contamination, a ProteoSpin endotoxin removal kit was used 
(Norgen Biotek Corporation, Thorold, Canada). Purified MAT.Ang-1 was used at 33 µg/mouse, a dose previously 
shown to reverse LPS-induced inflammation in mice27. MAT.Ang-1 (33 µg/2 ml) or the equivalent volume of 
saline or purified low endotoxin human serum albumin (Sigma-Aldrich, Poole, UK) was injected i.p. into C57Bl/6 
mice. Alternatively, peritonitis was induced by administration of thioglycollate as previously described51. After 0, 
2 or 4 h, peritoneal lavage was performed on mice as previously described51, 52. The total leukocyte count was cal-
culated using a haemocytometer and the differential count was determined by preparing a cytospin stained with 
Hema Gurr® Rapid Stain set (VWR, Lutterworth, UK). Cytometric bead array (Becton Dickinson Bioscience, 
Oxford, UK) or ELISA (mouse Ang-1 PicoKine™ ELISA kit, Boster Biological Technology, Pleasanton, CA) was 
performed on lavage fluid samples in order to measure any changes in cytokine or Ang-1 content respectively.
Intraperitoneal macrophage depletion. In order to deplete resident peritoneal macrophages prior to 
repeating the above peritonitis experiments, C57/Bl6 mice were injected i.p. with 250 µl control or clodronate 
liposomes (Encapsula Nano Sciences, Nashville, TN) as previously described53–55. After 48 h, peritoneal lavage 
was collected and total leukocyte and differential counts performed as above. Additionally, to analyse any effects 
of liposome treatment on circulating leukocyte levels, whole blood was taken by cardiac puncture and total leu-
kocyte counts calculated using a haemocytometer. Differential blood counts were determined using a Sysmex 
hematology analyser (Sysmex Inc, Milton Keynes, UK).
Statistical Analysis. Results are presented as mean ± standard error (SEM). Statistical analyses were per-
formed using GraphPad Prism version 6 (GraphPad Software, San Diego, CA). One- or two-way analysis of 
variance followed by Dunnett’s or Bonferroni’s post tests were performed on appropriate data sets. P values less 
than 0.05 were considered significant.
Data Availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on reasonable request.
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